Natural product pectolinarigenin inhibits proliferation, induces apoptosis, and causes G2/M phase arrest of HCC via PI3K/AKT/mTOR/ERK signaling pathway

References

• FornerAReigMBruixJHepatocellular carcinomaLancet2018391101271301131429307467
   PubMed Web of Science ®Google Scholar
• FornerALlovetJMBruixJHepatocellular carcinomaLancet201237998221245125522353262
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAmerican Association for the Study of Liver D. Management of hepatocellular carcinoma: an updateHepatology20115331020102221374666
   PubMed Web of Science ®Google Scholar
• European Association For The Study Of The Liver, European Organisation For Research And Treatment Of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• MuthuCReeganADKingsleySIgnacimuthuSLarvicidal activity of pectolinaringenin from Clerodendrum phlomidis L. against Culex quin-quefasciatus Say and Aedes aegypti L. (Diptera: Culicidae)Parasitol Res201211131059106522562213
   PubMed Web of Science ®Google Scholar
• SujathaPSreekanthGKhasimSAdavi RaoBVRavi KumarBAppa RaoAVFlavonoids of dikamali: a phytochemical reinvestigationNat Prod Res201327201930193223537094
   PubMed Web of Science ®Google Scholar
• LimHSonKHChangHWBaeKKangSSKimHPAnti-inflammatory activity of pectolinarigenin and pectolinarin isolated from Cirsium chanroenicumBiol Pharm Bull200831112063206718981574
   PubMed Web of Science ®Google Scholar
• BonesiMTundisRDeguinBIn vitro biological evaluation of novel 7-O-dialkylaminoalkyl cytotoxic pectolinarigenin derivatives against a panel of human cancer cell linesBioorg Med Chem Lett200818205431543418818071
   PubMed Web of Science ®Google Scholar
• ElmoreSApoptosis: a review of programmed cell deathToxicol Pathol200735449551617562483
   PubMed Web of Science ®Google Scholar
• BrayFFerlayJLaversanneMCancer Incidence in Five Continents: inclusion criteria, highlights from Volume X and the global status of cancer registrationInt J Cancer201513792060207126135522
   PubMed Web of Science ®Google Scholar
• LlovetJMZucman-RossiJPikarskyEHepatocellular carcinomaNat Rev Dis Primers201621601827158749
   PubMed Web of Science ®Google Scholar
• Zucman-RossiJVillanuevaANaultJCLlovetJMGenetic landscape and biomarkers of hepatocellular carcinomaGastroenterology201514951226123926099527
   PubMed Web of Science ®Google Scholar
• LlovetJMLencioniRDi BisceglieAMEASL-EORTC Clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• CarlsonRWLarsenJKMcclureJInternational adaptations of NCCN clinical practice guidelines in oncologyJ Natl Compr Canc Netw201412564364824812133
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• BruixJQinSMerlePRegorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trialLancet201738910064566627932229
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• El-KhoueiryABSangroBYauTNivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trialLancet2017389100882492250228434648
   PubMed Web of Science ®Google Scholar
• LuMKongQXuXPectolinarigenin – A flavonoid compound from cirsium japonicum with potential anti-proliferation activity in MCF-7 breast cancer cellTrop J Pharm Res2014132225228
   Web of Science ®Google Scholar
• WoerdenbagHJMerfortIPassreiterCMCytotoxicity of flavonoids and sesquiterpene lactones from Arnica species against the GLC4 and the COLO 320 cell linesPlanta Med19946054344377997472
   PubMed Web of Science ®Google Scholar
• JiaLTChenSYYangAGCancer gene therapy targeting cellular apoptosis machineryCancer Treat Rev201238786887622800735
   PubMed Web of Science ®Google Scholar
• GaoXHanLDingNBafilomycin C1 induces G0/G1 cell-cycle arrest and mitochondrial-mediated apoptosis in human hepatocellular cancer SMMC7721 cellsJ Antibiot201871980881729752478
   PubMed Web of Science ®Google Scholar
• TsujimotoYFingerLRYunisJNowellPCCroceCMCloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocationScience19842264678109710996093263
   PubMed Web of Science ®Google Scholar
• TsujimotoYCossmanJJaffeECroceCMInvolvement of the bcl-2 gene in human follicular lymphomaScience19852284706144014433874430
   PubMed Web of Science ®Google Scholar
• KitadaSTakayamaSde RielKTanakaSReedJCReversal of chemoresistance of lymphoma cells by antisense-mediated reduction of bcl-2 gene expressionAntisense Res Dev19944271797950302
   PubMedGoogle Scholar
• TóthováEFricovaMStecováNKafkováAElbertováAHigh expression of Bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapyNeoplasma200249314114412097997
   PubMed Web of Science ®Google Scholar
• CroceCMReedJCFinally, an apoptosis-targeting therapeutic for cancerCancer Res201676205914592027694602
   PubMed Web of Science ®Google Scholar
• RaiNKTripathiKSharmaDShuklaVKApoptosis: a basic physiologic process in wound healingInt J Low Extrem Wounds20054313814416100094
   PubMedGoogle Scholar
• CohenGMCaspases: the executioners of apoptosisBiochem J199732611169337844
   PubMed Web of Science ®Google Scholar
• MalumbresMBarbacidMCell cycle, CDKs and cancer: a changing paradigmNat Rev Cancer20099315316619238148
   PubMed Web of Science ®Google Scholar
• WilliamsGHStoeberKThe cell cycle and cancerJ Pathol2012226235236421990031
   PubMed Web of Science ®Google Scholar
• XiongYHannonGJZhangHCassoDKobayashiRBeachDp21 is a universal inhibitor of cyclin kinasesNature199336664567017048259214
   PubMed Web of Science ®Google Scholar
• MatterMSDecaensTAndersenJBThorgeirssonSSTargeting the mTOR pathway in hepatocellular carcinoma: current state and future trendsJ Hepatol201460485586524308993
   PubMed Web of Science ®Google Scholar
• YangSLiuGTargeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinomaOncol Lett20171331041104728454211
   PubMed Web of Science ®Google Scholar
• MukhopadhyaySSaqcenaMFosterDASynthetic lethality in KRas-driven cancer cells created by glutamine deprivationOncoscience201521080780826682255
   PubMedGoogle Scholar
• MukhopadhyaySChatterjeeAKoganDPatelDFosterDA5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cellsCell Cycle201514203331333926323019
   PubMed Web of Science ®Google Scholar
• KirsteinMMBoukourisAEPothirajuDActivity of the mTOR inhibitor RAD001, the dual mTOR and PI3-kinase inhibitor BEZ235 and the PI3-kinase inhibitor BKM120 in hepatocellular carcinomaLiver Int201333578079323489999
   PubMed Web of Science ®Google Scholar
• NgKYChanLHChaiSTP53INP1 downregulation activates a p73-Dependent DUSP10/ERK signaling pathway to promote metastasis of hepatocellular carcinomaCancer Res201777174602461228674078
   PubMed Web of Science ®Google Scholar